Neuroinflammation in suicide: Toward a comprehensive model

World Journal of Biological Psychiatry

Volumn 17, Issue 8, 2016, Pages 564-586

  Courtet, Philippe ^a,b,c   Giner, Lucas ^d   Seneque, Maude ^a,b,c   Guillaume, Sebastien ^a,b,c   Olie, Emilie ^a,b,c   Ducasse, Deborah ^a,b,c  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c FONDATION FONDAMENTAL   (France)

^d UNIVERSITY OF SEVILLE   (Spain)

Author keywords

biomarker; inflammation; microglia; social ties; suicidal behaviour

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; EOTAXIN; EOTAXIN 3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; KYNURENINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; OREXIN; QUINOLINIC ACID; RANTES; SEROTONIN; STROMELYSIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; CYTOKINE;

AUTOPSY; CHILDHOOD INJURY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; IMMUNOPATHOGENESIS; IMPULSIVENESS; MEDIATOR RELEASE; MENTAL STRESS; MODEL; MONOAMINERGIC SYSTEM; NERVOUS SYSTEM INFLAMMATION; NEUROBIOLOGY; NEUROTRANSMISSION; ORBITAL CORTEX; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; INFLAMMATION; MENTAL DISORDERS; MICROGLIA; PATHOLOGY; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BIOMARKERS; CYTOKINES; HUMANS; INFLAMMATION; MENTAL DISORDERS; MICROGLIA; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUICIDE, ATTEMPTED;

EID: 84938634028     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2015.1054879     Document Type: Review

References (191)

1. J.Aliberti, A.Bafica. 2005. Anti-inflammatory pathways as a host evasion mechanism for pathogens. Prostaglandins Leukot Essent Fatty Acids 73:283–288.
2. T.A.Arling, R.H.Yolken, M.Lapidus, P.Langenberg, F.B.Dickerson, S.A.Zimmerman,. 2009. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 197:905–908.
3. S.Artero, B.Astruc, P.Courtet, K.Ritchie. 2006. Life-time history of suicide attempts and coronary artery disease in a community-dwelling elderly population. Int J Geriatr Psychiatry 21:108–112.
4. N.M.Asano, M.Coriolano, B.J.Asano, O.G.Lins. 2013. Psychiatric comorbidities in patients with systemic lupus erythematosus:a systematic review of the last 10 years. Rev Bras Reumatol 53:431–437.
5. E.D.Ballard, D.F.Ionescu, J.L.Vande Voort, M.J.Niciu, E.M.Richards, D.A.Luckenbaugh,. 2014. Improvement in suicidal ideation after ketamine infusion:relationship to reductions in depression and anxiety. J Psychiatr Res 58:161–166.
6. D.A.Baron, T.Hardie, S.H.Baron. 1993. Possible association of interleukin-2 treatment with depression and suicide. J Am Osteopath Assoc 93:799–800.
7. R.F.Baumeister, M.R.Leary. 1995. The need to belong:desire for interpersonal attachments as a fundamental human motivation. Psychol Bull 117:497–529.
8. C.Bay-Richter, K.R.Linderholm, C.K.Lim, M.Samuelsson, L.Traskman-Bendz, G.J.Guillemin,. 2015. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain Behav Immun 43:110–117.
9. L.Bayard-Burfield, C.Alling, K.Blennow, S.Jonsson, L.Traskman-Bendz. 1996. Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol 6:195–199.
10. H.Bergen, K.Hawton, K.Waters, J.Ness, J.Cooper, S.Steeg,. 2012. Premature death after self-harm:a multicentre cohort study. Lancet 380:1568–1574.
11. R.M.Berman, A.Cappiello, A.Anand, D.A.Oren, G.R.Heninger, D.S.Charney,. 2000. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354.
12. C.Black, B.J.Miller. 2014. Meta-analysis of cytokines and chemokines in suicidality:distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry 78:28–37.
13. H.Bronnum-Hansen, E.Stenager, E.Nylev Stenager, N.Koch-Henriksen. 2005. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 76:1457–1459.
14. P.A.Bryant, J.Trinder, N.Curtis. 2004. Sick and tired:Does sleep have a vital role in the immune system? Nat Rev Immunol 4:457–467.
15. J.T.Cacioppo, L.C.Hawkley. 2003. Social isolation and health, with an emphasis on underlying mechanisms. Perspect Biol Med 46, S39–52.
16. J.T.Cacioppo, L.C.Hawkley, L.E.Crawford, J.M.Ernst, M.H.Burleson, R.B.Kowalewski,. 2002. Loneliness and health:potential mechanisms. Psychosom Med 64:407–417.
17. L.Capuron, G.Pagnoni, M.Demetrashvili, B.J.Woolwine, C.B.Nemeroff, G.S.Berns,. 2005. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 58:190–196.
18. A.Carlborg, J.Jokinen, E.G.Jonsson, S.Erhardt, P.Nordstrom. 2013. CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis. Psychiatry Res 205:165–167.
19. J.E.Carroll, C.A.Low, A.A.Prather, S.Cohen, J.M.Fury, D.C.Ross,. 2011. Negative affective responses to a speech task predict changes in interleukin (IL)-6. Brain Behav Immun 25:232–238.
20. C.Christodoulou, A.Douzenis, F.C.Papadopoulos, A.Papadopoulou, G.Bouras, R.Gournellis,. 2012. Suicide and seasonality. Acta Psychiatr Scand 125:127–146.
21. A.Cipriani, K.Hawton, S.Stockton, J.R.Geddes. 2013. Lithium in the prevention of suicide in mood disorders:updated systematic review and meta-analysis. Br Med J 346:f3646.
22. E.F.Coccaro, R.Lee, M.Coussons-Read. 2014. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. J Am Med Assoc Psychiatry 71:158–165.
23. R.Coelho, T.W.Viola, C.Walss-Bass, E.Brietzke, R.Grassi-Oliveira. 2014. Childhood maltreatment and inflammatory markers:a systematic review. Acta Psychiatr Scand 129:180–192.
24. S.W.Cole, L.C.Hawkley, J.M.Arevalo, C.Y.Sung, R.M.Rose, J.T.Cacioppo. 2007. Social regulation of gene expression in human leukocytes. Genome Biol 8:R189.
25. P.Courtet, I.I.Gottesman, F.Jollant, T.D.Gould,. 2011. The neuroscience of suicidal behaviors:what can we expect from endophenotype strategies? Transl Psychiatry 1, pii:e7.
26. P.Courtet. 2013. Suicide et environnement social. Paris:DUNOD.
27. J.Couzin-Frankel. 2010. Inflammation bares a dark side. Science 330:1621.
28. A.Danese, B.S.McEwen. 2012. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav 106:29–39.
29. A.Danese, T.E.Moffitt, C.M.Pariante, A.Ambler, R.Poulton, A.Caspi. 2008. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65:409–415.
30. J.Danesh, P.Whincup, M.Walker, L.Lennon, A.Thomson, P.Appleby,. 2000. Low grade inflammation and coronary heart disease:prospective study and updated meta-analyses. Br Med J 321:199–204.
31. R.Dantzer, J.C.O’Connor, G.G.Freund, R.W.Johnson, K.W.Kelley. 2008. From inflammation to sickness and depression:when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56.
32. N.DiazGranados, L.A.Ibrahim, N.E.Brutsche, R.Ameli, I.D.Henter, D.A.Luckenbaugh,. 2010. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 71:1605–1611.
33. N.Dich, A.M.Hansen, K.Avlund, R.Lund, E.L.Mortensen, H.Bruunsgaard,. 2014. Early life adversity potentiates the effects of later life stress on cumulative physiological dysregulation. Anxiety Stress Coping 1–19.
34. S.S.Dickerson, S.L.Gable, M.R.Irwin, N.Aziz, M.E.Kemeny. 2009. Social-evaluative threat and proinflammatory cytokine regulation:an experimental laboratory investigation. Psychol Sci 20:1237–1244.
35. L.J.Dietz, S.Stoyak, N.Melhem, G.Porta, K.A.Matthews, M.Walker Payne,. 2013. Cortisol response to social stress in parentally bereaved youth. Biol Psychiatry 73:379–387.
36. H.Dong, X.Zhang, X.Dai, S.Lu, B.Gui, W.Jin,. 2014. Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway. J Neuroinflammation 11:140.
37. Y.Dowlati, N.Herrmann, W.Swardfager, H.Liu, L.Sham, E.K.Reim,. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457.
38. D.Ducasse, E.Olié, S.Guillaume, S.Artero, P.Courtet. 2015. A meta-analysis of cytokines in suicidal beahvior. Brain Behav Immun 46:203–211.
39. D.Ducasse, E.Rene, S.Beziat, S.Guillaume, P.Courtet, E.Olie. 2014. Acceptance and commitment therapy for management of suicidal patients:a pilot study. Psychother Psychosom 83:374–376.
40. N.I.Eisenberger. 2012. The pain of social disconnection:examining the shared neural underpinnings of physical and social pain. Nat Rev Neurosci 13:421–434.
41. N.I.Eisenberger, M.D.Lieberman. 2004. Why rejection hurts:a common neural alarm system for physical and social pain. Trends Cogn Sci 8:294–300.
42. S.Erhardt, C.K.Lim, K.R.Linderholm, S.Janelidze, D.Lindqvist, M.Samuelsson,. 2013. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:743–752.
43. T.Falcone, V.Fazio, C.Lee, B.Simon, K.Franco, N.Marchi,. 2010. Serum SB100:a potential biomarker for suicidality in adolescents? PloS One 5:e11089.
44. L.Fardet, I.Petersen, I.Nazareth. 2012. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 169:491–497.
45. A.Feinstein. 2002. An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674–678.
46. A.Feinstein. 2011. Multiple sclerosis and depression. Mult Scler 17:1276–1281.
47. J.C.Felger, F.E.Lotrich. 2013. Inflammatory cytokines in depression:neurobiological mechanisms and therapeutic implications. Neuroscience 246:199–229.
48. Y.D.Fragoso, E.R.Frota, J.S.Lopes, J.S.Noal, M.C.Giacomo, S.Gomes,. 2010. Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuropharmacol 33:312–316.
49. S.Fredrikson, Q.Cheng, G.Jiang, D.Wasserman. 2003. Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 22:146–152.
50. K.Fukunishi, H.Tanaka, J.Maruyama, H.Takahashi, H.Kitagishi, T.Ueshima,. 1998. Burns in a suicide attempt related to psychiatric side effects of interferon. Burns 24:581–583.
51. V.Gabbay, R.G.Klein, L.E.Guttman, J.S.Babb, C.M.Alonso, M.Nishawala,. 2009. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmacol 19:423–430.
52. H.Galfalvy, J.J.Mann. 2011. Cerebrospinal fluid biomarkers in suicide attempters. Acta Psychiatr Scand 124:4–5.
53. L.Gettings. 2010. Psychological well-being in rheumatoid arthritis:a review of the literature. Musculoskeletal Care 8:99–106.
54. D.S.Goodin, M.Corwin, D.Kaufman, H.Golub, S.Reshef, M.J.Rametta,. 2014. Causes of death among commercially insured multiple sclerosis patients in the United States. PloS One 9:e105207.
55. R.D.Goodwin, W.W.Eaton,. 2005. Asthma, suicidal ideation, and suicide attempts:findings from the Baltimore epidemiologic catchment area follow-up. Am J Public Health 95:717–722.
56. R.D.Goodwin, K.Messineo, A.Bregante, C.W.Hoven, R.Kairam. 2005. Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J Asthma 42:643–647.
57. R.Grassi-Oliveira, E.Brieztke, A.Teixeira, J.C.Pezzi, M.Zanini, R.P.Lopes,. 2012. Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Rev Bras Psiquiatr 34:71–75.
58. J.F.Greden. 2001. The burden of disease for treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):26–31.
59. R.A.Hackett, M.Hamer, R.Endrighi, L.Brydon, A.Steptoe. 2012. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology 37:1801–1809.
60. M.L.Hanke, T.Kielian. 2011. Toll-like receptors in health and disease in the brain:mechanisms and therapeutic potential. Clin Sci (London) 121:367–387.
61. E.Haroon, C.L.Raison, A.H.Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology:translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137–162.
62. E.C.Harris, B.M.Barraclough. 1994. Suicide as an outcome for medical disorders. Medicine (Baltimore) 73:281–296.
63. S.Henningsson, F.Baghaei, R.Rosmond, G.Holm, M.Landen, H.Anckarsater,. 2008. Association between serum levels of C-reactive protein and personality traits in women. Behav Brain Funct 4:16.
64. F.Holsboer. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501.
65. P.C.Hsu, M.Groer, T.Beckie. 2014. New findings:Depression, suicide, and Toxoplasma gondii infection. J Am Assoc Nurse Pract 26:629–637.
66. T.L.Huang, C.T.Lee. 2007. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci 61:415–420.
67. M.R.Irwin, S.W.Cole. 2011. Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 11:625–632.
68. E.Isometsa, M.Heikkinen, M.Henriksson, H.Aro, J.Lonnqvist. 1995. Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides. J Affect Disord 33:99–106.
69. J.Isung, S.Aeinehband, F.Mobarrez, B.Martensson, P.Nordstrom, M.Asberg,. 2012a. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2, e196.
70. J.Isung, F.Mobarrez, P.Nordstrom, M.Asberg, J.Jokinen. 2012b. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry 13:468–473.
71. S.Janelidze, D.Mattei, A.Westrin, L.Traskman-Bendz, L.Brundin. 2011. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 25:335–339.
72. S.Janelidze, F.Ventorp, S.Erhardt, O.Hansson, L.Minthon, J.Flax,. 2013. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology 38:853–862.
73. S.Janelidze, P.Suchankova, A.Ekman, S.Erhardt, C.Sellgren, M.Samuelsson,. 2014. Low IL-8 is associated with anxiety in suicidal patients:genetic variation and decreased protein levels. Acta Psychiatr Scand 1–10.
74. H.L.Janssen, J.T.Brouwer, R.C.van der Mast, S.W.Schalm. 1994. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 21:241–243.
75. T.Joiner. 2005. Why people die by suicide. Cambridge, MA:Harvard University Press.
76. F.Jollant, N.S.Lawrence, V.Giampietro, M.J.Brammer, M.A.Fullana, D.Drapier,. 2011. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry 165:740–748.
77. D.Karlovic, A.Serretti, N.Vrkic, M.Martinac, D.Marcinko. 2012. Serum concentrations of CRP, IL6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res 198:74–80.
78. Y.K.Kim, S.W.Lee, S.H.Kim, S.H.Shim, S.W.Han, S.H.Choi,. 2008. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:356–361.
79. K.L.Knox, D.A.Litts, G.W.Talcott, J.C.Feig, E.D.Caine. 2003. Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force:cohort study. Br Med J 327:1376.
80. M.Kodaka, T.Matsumoto, Y.Katsumata, M.Akazawa, H.Tachimori, N.Kawakami,. 2014. Suicide risk among individuals with sleep disturbances in Japan:a case-control psychological autopsy study. Sleep Med 15:430–435.
81. M.R.Kraus, A.Schafer, H.Faller, H.Csef, M.Scheurlen. 2003. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 64:708–714.
82. A.Kudoh, Y.Takahira, H.Katagai, T.Takazawa. 2002. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95:114–118, table of contents.
83. B.Labonte, V.Yerko, J.Gross, N.Mechawar, M.J.Meaney, M.Szyf,. 2012. Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biol Psychiatry 72:41–48.
84. M.A.Lana-Peixoto, A.L.TeixeiraJr, V.G.Haase. 2002. Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis. Arq Neuropsiquiatr 60:721–724.
85. S.Lanquillon, J.C.Krieg, U.Bening-Abu-Shach, H.Vedder. 2000. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379.
86. G.L.Larkin, A.L.Beautrais. 2011. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 14:1127–1131.
87. H.Y.Lee, Y.K.Kim. 2010. Transforming growth factor-beta1 and major depressive disorder with and without attempted suicide:preliminary study. Psychiatry Res 178:92–96.
88. B.Leonard 2000. Stress, depression and the activation of the immune system. World J Biol Psychiatry 1:17–25.
89. D.Lester. 1992. The dexamethasone suppression test as an indicator of suicide:a meta-analysis. Pharmacopsychiatry 25:265–270.
90. H.Li, Q.Li, X.Du, Y.Sun, X.Wang, G.Kroemer,. 2011. Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab 31:2106–2115.
91. Z.Li, D.Qi, J.Chen, C.Zhang, Z.Yi, C.Yuan,. 2013. Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-alpha) in the Chinese patients with major depressive disorder:a prospective longitudinal study. Psychoneuroendocrinology 38:107–114.
92. D.Lindqvist, S.Janelidze, S.Erhardt, L.Traskman-Bendz, G.Engstrom, L.Brundin. 2011. CSF biomarkers in suicide attempters–a principal component analysis. Acta Psychiatr Scand 124:52–61.
93. D.Lindqvist, S.Janelidze, P.Hagell, S.Erhardt, M.Samuelsson, L.Minthon,. 2009. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66:287–292.
94. V.J.Ling, D.Lester, P.B.Mortensen, P.W.Langenberg, T.T.Postolache. 2011. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 199:440–444.
95. F.E.Lotrich, R.E.Ferrell, M.Rabinovitz, B.G.Pollock. 2010. Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol 33:191–197.
96. Y.Matsukawa, S.Sawada, T.Hayama, H.Usui, T.Horie. 1994. Suicide in patients with systemic lupus erythematosus:a clinical analysis of seven suicidal patients. Lupus 3:31–35.
97. A.McGirr, G.Diaconu, M.T.Berlim, J.C.Pruessner, R.Sable, S.Cabot,. 2010. Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci 35:399–408.
98. P.O.McGowan, A.Sasaki, A.C.D’Alessio, S.Dymov, B.Labonte, M.Szyf,. 2009. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348.
99. L.McNally, Z.Bhagwagar, J.Hannestad. 2008. Inflammation, glutamate, and glia in depression:a literature review. CNS Spectr 13:501–510.
100. H.K.Meier-Ewert, P.M.Ridker, N.Rifai, M.M.Regan, N.J.Price, D.F.Dinges,. 2004. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683.
101. S.Mendlovic, E.Mozes, E.Eilat, A.Doron, J.Lereya, V.Zakuth,. 1999. Immune activation in non-treated suicidal major depression. Immunol Lett 67:105–108.
102. G.E.Miller, E.Chen, K.J.Parker. 2011. Psychological stress in childhood and susceptibility to the chronic diseases of aging:moving toward a model of behavioral and biological mechanisms. Psychol Bull 137:959–997.
103. A.M.Mitchell, P.Possel, E.Sjogren, M.Kristenson. 2013. Hopelessness the “active ingredient”? Associations of hopelessness and depressive symptoms with interleukin-6. Int J Psychiatry Med 46:109–117.
104. A.Modabbernia, S.Taslimi, E.Brietzke, M.Ashrafi. 2013. Cytokine alterations in bipolar disorder:a meta-analysis of 30 studies. Biol Psychiatry 74:15–25.
105. C.C.Mok, K.L.Chan, E.F.Cheung, P.S.Yip. 2014. Suicidal ideation in patients with systemic lupus erythematosus:incidence and risk factors. Rheumatology (Oxford) 53:714–721.
106. X.Monfrim, M.Gazal, P.B.De Leon, L.Quevedo, L.D.Souza. 2014. Immune dysfunction in bipolar disorder and suicide risk:is there an association between peripheral corticotropin-releasing hormone and interleukin-1b? Bipolar Disord 16:741–747.
107. S.J.Motivala, A.Sarfatti, L.Olmos, M.R.Irwin. 2005. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67:187–194.
108. N.Muller, M.J.Schwartz. 2007. The immune-mediated alteration of serotonin and glutamate:towards and integrated view of depression. Mol Psychiatry 12:988–1000.
109. J.M.Mullington, M.Haack, M.Toth, J.M.Serrador, H.K.Meier-Ewert. 2009.
110. Cadiovascular, inflammatory and metabolic consequences of sleep deprivation. Progr Cardiovasc Dis 51:294–302.
111. M.L.Murphy, G.M.Slavich, N.Rohleder, G.E.Miller. 2013. Targeted rejection triggers differential pro- and anti-inflammatory gene expression in adolescents as a function of social status. Clin Psychol Sci 1:30–40.
112. G.Nowak, G.A.Ordway, I.A.Paul. 1995. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157–164.
113. A.O’Donovan, J.Lin, J.Tillie, F.S.Dhabhar, O.M.Wolkowitz, E.H.Blackburn,. 2009. Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women. Brain Behav Immun 23:446–449.
114. A.O’Donovan, G.Rush, G.Hoatam, B.M.Hughes, A.McCrohan, C.Kelleher,. 2013. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anx 30:307–314.
115. O.Okusaga, P.Langenberg, A.Sleemi, D.Vaswani, I.Giegling, A.M.Hartmann,. 2011. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 133:150–155.
116. O.Okusaga, T.T.Postolache. 2012. Toxoplasma gondii, the immune system, and suicidal behavior. In:Y.Dwivedi, editor. Source. The Neurobiological Basis of Suicide. Boca Raton, FL:CRC Press. Chapter 19. Frontiers in neuroscience.
117. M.D.Omrani, M.Bagheri, B.Bushehri, F.Azizi, M.R.Anoshae. 2012. The association of TGF-beta1 codon 10 polymorphism with suicide behavior. Am J Med Genet B Neuropsychiatr Genet 159B:772–775.
118. M.D.Omrani, B.Bushehri, M.Bagheri, S.Salaki-Lak, A.Alipour, M.R.Anoshae,. 2009. Role of IL-10 -1082, IFN-gamma + 874, and TNF-alpha -308 genes polymorphisms in suicidal behavior. Arch Suicide Res 13:330–339.
119. M.R.Opp, J.Born, M.R.Irwin. 2007. Sleep and the immune system. In:R.Ader, editor. Psychoneuroimmunology. New York, NY:Academic Press. p 570–618.
120. M.A.Oquendo, H.Galfalvy, S.Russo, S.P.Ellis, M.F.Grunebaum, A.Burke,. 2004. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 161:1433–1441.
121. T.W.Pace, L.T.Negi, D.D.Adame, S.P.Cole, T.I.Sivilli, T.D.Brown,. 2009. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 34:87–98.
122. G.N.Pandey, H.S.Rizavi, X.Ren, R.Bhaumik, Y.Dwivedi. 2014. Toll-like receptors in the depressed and suicide brain. J Psychiatr Res 53:62–68.
123. G.N.Pandey, H.S.Rizavi, X.Ren, Y.Dwivedi, M.Palkovits. 2013. Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims. Psychoneuroendocrinology 38:2628–2639.
124. G.N.Pandey, H.S.Rizavi, X.Ren, J.Fareed, D.A.Hoppensteadt, R.C.Roberts,. 2012. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 46:57–63.
125. M.G.Pedersen, P.B.Mortensen, B.Norgaard-Pedersen, T.T.Postolache. 2012. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 69:1123–1130.
126. J.M.Perez-Ortiz, M.S.Garcia-Gutierrez, F.Navarrete, S.Giner, J.Manzanares. 2013. Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 38:1251–1258.
127. N.Perroud, P.Baud, S.Ardu, I.Krejci, D.Mouthon, M.Vessaz,. 2013. Temperament personality profiles in suicidal behaviour:an investigation of associated demographic, clinical and genetic factors. J Affect Disord 146:246–253.
128. N.Perroud, P.Baud, D.Mouthon, P.Courtet, A.Malafosse. 2011. Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders. J Affect Disord 134:112–118.
129. N.Perroud, P.Courtet, I.Vincze, I.Jaussent, F.Jollant, F.Bellivier,. 2008. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav 7:314–322.
130. N.Pinho de Oliveira Ribeiro, A.Rafael de Mello Schier, A.C.Ornelas, C.M.Pinho de Oliveira, A.E.Nardi, A.C.Silva. 2013. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Compr Psychiatry 54:1185–1189.
131. T.T.Postolache, P.B.Mortensen, L.H.Tonelli, X.Jiao, C.Frangakis, J.J.Soriano,. 2010. Seasonal spring peaks of suicide in victims with and without prior history of hospitalization for mood disorders. J Affect Disord 121:88–93.
132. T.T.Postolache, J.W.Stiller, R.Herrell, M.A.Goldstein, S.S.Shreeram, R.Zebrak,. 2005. Tree pollen peaks are associated with increased nonviolent suicide in women. Mol Psychiatry 10:232–235.
133. S.Potvin, E.Stip, A.A.Sepehry, A.Gendron, R.Bah, E.Kouassi. 2008. Inflammatory cytokine alterations in schizophrenia:a systematic quantitative review. Biol Psychiatry 63:801–808.
134. R.B.Price, D.V.Iosifescu, J.W.Murrough, L.C.Chang, R.K.Al Jurdi, S.Z.Iqbal,. 2014. Effects of ketamine on explicit and implicit suicidal cognition:a randomized controlled trial in treatment-resistant depression. Depress Anx 31:335–343.
135. R.B.Price, M.K.Nock, D.S.Charney, S.J.Mathew. 2009. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66:522–526.
136. P.Qin, P.B.Mortensen, B.L.Waltoft, T.T.Postolache. 2011. Allergy is associated with suicide completion with a possible mediating role of mood disorder – a population-based study. Allergy 66:658–664.
137. C.L.Raison, A.H.Miller. 2003. When not enough is too much:the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160:1554–1565.
138. C.L.Raison, R.E.Rutherford, B.J.Woolwine, C.Shuo, P.Schettler, D.F.Drake,. 2013. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment- resistant depression:the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31–41.
139. J.D.Ribeiro, T.E.Joiner. 2009. The interpersonal-psychological theory of suicidal behavior:current status and future directions. J Clin Psychol 65:1291–1299.
140. B.Roy, A.V.Diez-Roux, T.Seeman, N.Ranjit, S.Shea, M.Cushman. 2010. Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom Med 72:134–140.
141. D.Rujescu, I.Giegling. 2010. The genetics of neurosystems in mental ill-health and suicidality:beyond serotonin. Eur Psychiatry 25:272–274.
142. A.D.Sadovnick, K.Eisen, G.C.Ebers, D.W.Paty. 1991. Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196.
143. P.A.Saiz, P.Garcia-Portilla, B.Paredes, C.Arango, B.Morales, V.Alvarez,. 2008. Association study of the interleukin-1 gene complex and tumor necrosis factor alpha gene with suicide attempts. Psychiatr Genet 18:147–150.
144. P.A.Saiz, P.Garcia-Portilla, B.Paredes, P.Corcoran, C.Arango, B.Morales,. 2011. Role of serotonergic-related systems in suicidal behavior:data from a case-control association study. Prog Neuropsychopharmacol Biol Psychiatry 35:1518–1524.
145. T.P.Schnieder, I.Trencevska, G.Rosoklija, A.Stankov, J.J.Mann, J.Smiley,. 2014. Microglia of prefrontal white matter in suicide. J Neuropathol Exp Neurol 73:880–890.
146. R.Schwarcz, P.Guidetti, K.V.Sathyasaikumar, P.J.Muchowski. 2010. Of mice, rats and men:Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol 90:230–245.
147. A.Sequeira, L.Morgan, D.M.Walsh, P.M.Cartagena, P.Choudary, J.Li,. 2012. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PloS One 7, e35367.
148. G.M.Slavich, S.W.Cole. 2013. The emerging field of human social genomics. Clin Psychol Sci 1:331–348.
149. G.M.Slavich, T.Thornton, L.D.Torres, S.M.Monroe, I.H.Gotlib. 2009. Targeted rejection predicts hastened onset of major depression. J Soc Clin Psychol 28:223–243.
150. S.Sockalingam, P.S.Links, S.E.Abbey. 2011. Suicide risk in hepatitis C and during interferon-alpha therapy:a review and clinical update. J Viral Hepat 18:153–160.
151. J.Steiner, H.Bielau, R.Brisch, P.Danos, O.Ullrich, C.Mawrin,. 2008. Immunological aspects in the neurobiology of suicide:elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42:151–157.
152. J.Steiner, C.Mawrin, A.Ziegeler, H.Bielau, O.Ullrich, H.G.Bernstein,. 2006. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 112:305–316.
153. J.Steiner, M.Walter, T.Gos, G.J.Guillemin, H.G.Bernstein, Z.Sarnyai,. 2011. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus:evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8:94.
154. E.N.Stenager, E.Stenager, N.Koch-Henriksen, H.Bronnum-Hansen, K.Hyllested, K.Jensen,. 1992. Suicide and multiple sclerosis:an epidemiological investigation. J Neurol Neurosurg Psychiatry 55:542–545.
155. M.J.Stuart, B.T.Baune. 2014. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment:a systematic review of biomarker studies. Neurosci Biobehav Rev 42:93–115.
156. E.C.Suarez. 2008. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress:evidence for gender disparity. Brain Behav Immun 22:960–968.
157. M.E.Sublette, H.C.Galfalvy, D.Fuchs, M.Lapidus, M.F.Grunebaum, M.A.Oquendo,. 2011. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun 25:1272–1278.
158. P.Suchankova, S.Henningsson, F.Baghaei, R.Rosmond, G.Holm, A.Ekman. 2009. Genetic variability within the innate immune system influences personality traits in women. Genes Brain Behav 8:212–217.
159. P.Suchankova, G.Holm, L.Traskman-Bendz, L.Brundin, A.Ekman. 2013. The + 1444C> T polymorphism in the CRP gene:a study on personality traits and suicidal behaviour. Psychiatr Genet 23:70–76.
160. A.R.Sutin, A.Terracciano, B.Deiana, S.Naitza, L.Ferrucci, M.Uda,. 2010. High neuroticism and low conscientiousness are associated with interleukin-6. Psychol Med 40:1485–1493.
161. R.G.Thakurta, R.Das, A.K.Bhattacharya, D.Saha, S.Sen, O.P.Singh,. 2012. Rapid response with ketamine on suicidal cognition in resistant depression. Indian J Psychol Med 34:170–175.
162. J.Tiihonen, M.Virkkunen, P.Rasanen, S.Pennanen, E.L.Sainio, J.Callaway,. 2001. Free L-tryptophan plasma levels in antisocial violent offenders. Psychopharmacology (Berlin) 157:395–400.
163. M.Timonen, K.Viilo, H.Hakko, T.Sarkioja, V.B.Meyer-Rochow, E.Vaisanen,. 2004. Is seasonality of suicides stronger in victims with hospital-treated atopic disorders? Psychiatry Res 126:167–175.
164. M.Timonen, K.Viilo, H.Hakko, T.Sarkioja, M.Ylikulju, V.B.Meyer-Rochow,. 2003. Suicides in persons suffering from rheumatoid arthritis. Rheumatology (Oxford) 42:287–291.
165. L.H.Tonelli, J.Stiller, D.Rujescu, I.Giegling, B.Schneider, K.Maurer,. 2008. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 117:198–206.
166. S.G.Torres-Platas, C.Cruceanu, G.G.Chen, G.Turecki, N.Mechawar. 2014. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42:50–59.
167. S.G.Torres-Platas, C.Hercher, M.A.Davoli, G.Maussion, B.Labonte, G.Turecki,. 2011. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 36:2650–2658.
168. G.J.Treharne, A.C.Lyons, G.D.Kitas. 2000. Suicidal ideation in patients with rheumatoid arthritis. Research may help identify patients at high risk. Br Med J 321:1290.
169. N.A.Turiano, D.K.Mroczek, J.Moynihan, B.P.Chapman. 2013. Big 5 personality traits and interleukin-6:evidence for “healthy Neuroticism” in a US population sample. Brain Behav Immun 28:83–89.
170. A.P.Turner, R.M.Williams, J.D.Bowen, D.R.Rivlahan, J.K.Haselkorn. 2006. Suicidal ideation in multiple sclerosis. Arch Phys Med Rehabil 87:1073–1078.
171. M.Tursich, R.W.Neufeld, P.A.Frewen, S.Harricharan, J.L.Kibler, S.G.Rhind,. 2014. Association of trauma exposure with proinflammatory activity:a transdiagnostic meta-analysis. Transl Psychiatry 4, e413.
172. A.R.Tyrka, D.E.Burgers, N.S.Philip, L.H.Price, L.L.Carpenter. 2013. The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiatr Scand 128:434–447.
173. R.Uher, K.E.Tansey, T.Dew, W.Maier, O.Mors, J.Hauser,. 2014. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry.
174. G.Vaiva, F.Ducrocq, P.Meyer, D.Mathieu, A.Philippe, C.Libersa,. 2006. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department:randomised controlled study. BMJ 332:1241–1245.
175. V.Valkanova, K.P.Ebmeier, C.L.Allan. 2013. CRP, IL-6 and depression:a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150:736–744.
176. K.A.Van Orden, T.K.Witte, K.C.Cukrowicz, S.R.Braithwaite, E.A.Selby, T.E.Joiner. 2010. The interpersonal theory of suicide. Psychol Rev 117:575–600.
177. H.O.Vargas, S.O.Nunes, M.Pizzo de Castro, C.C.Bortolasci, D.Sabbatini Barbosa, H.Kaminami Morimoto,. 2013. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 150:923–930.
178. A.N.Vgontzas, D.A.Papanicolaou, E.O.Bixler, A.Lotsikas, K.Zachman, A.Kales,. 1999. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603–2607.
179. A.N.Vgontzas, E.Zoumakis, E.O.Bixler, H.M.Lin, H.Follett, A.Kales,. 2004. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89:2119–2126.
180. J.Vignau, M.Soichot, M.Imbenotte, M.C.Jacquemont, T.Danel, M.Vandamme,. 2010. Impact of tryptophan metabolism on the vulnerability to alcohol-related blackouts and violent impulsive behaviours. Alcohol Alcohol 45:79–88.
181. R.Viner, S.B.Patten, S.Berzins, A.G.Bulloch, K.M.Fiest. 2014. Prevalence and risk factors for suicidal ideation in a multiple sclerosis population. J Psychosom Res 76:312–316.
182. K.D.Williams. 2007. Ostracism. Annu Rev Psychol 58:425–452.
183. J.M.Woo, R.D.Gibbons, P.Qin, H.Komarow, J.B.Kim, C.A.Rogers,. 2011. Suicide and prescription rates of intranasal corticosteroids and nonsedating antihistamines for allergic rhinitis:an ecological study. J Clin Psychiatry 72:1423–1428.
184. J.M.Woo, O.Okusaga, T.T.Postolache. 2012. Seasonality of suicidal behavior. Int J Environ Res Public Health 9:531–547.
185. L.F.Xie, P.L.Chen, H.F.Pan, J.H.Tao, X.P.Li, Y.J.Zhang,. 2012. Prevalence and correlates of suicidal ideation in SLE inpatients:Chinese experience. Rheumatol Int 32:2707–2714.
186. F.Yagmur, S.Yazar, H.O.Temel, M.Cavusoglu. 2010. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 199:15–17.
187. K.Yamakawa, M.Matsunaga, T.Isowa, K.Kimura, K.Kasugai, M.Yoneda,. 2009. Transient responses of inflammatory cytokines in acute stress. Biol Psychol 82:25–32.
188. J.J.Yang, N.Wang, C.Yang, J.Y.Shi, H.Y.Yu, K.Hashimoto. 2015. Serum Interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry 77:e19–20.
189. R.Yirmiya, I.Goshen. 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25:181–213.
190. C.A.ZarateJr, N.E.Brutsche, L.Ibrahim, J.Franco-Chaves, N.Diazgranados, A.Cravchik,. 2012. Replication of ketamine's antidepressant efficacy in bipolar depression:a randomized controlled add-on trial. Biol Psychiatry 71:939–946.
191. Y.Zhang, L.Traskman-Bendz, S.Janelidze, P.Langenberg, A.Saleh, N.Constantine,. 2012. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry 73:1069–1076.